Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Yasmin Schmid, Florian Enzler, Peter Gasser, et al.
Biological Psychiatry (2014) Vol. 78, Iss. 8, pp. 544-553
Open Access | Times Cited: 388

Showing 1-25 of 388 citing articles:

Psychedelics
David E. Nichols
Pharmacological Reviews (2016) Vol. 68, Iss. 2, pp. 264-355
Open Access | Times Cited: 1304
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Robin Carhart‐Harris, Karl Friston
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 316-344
Open Access | Times Cited: 779
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Robin Carhart‐Harris, Suresh Muthukumaraswamy, Leor Roseman, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 17, pp. 4853-4858
Open Access | Times Cited: 751
Serotonin and brain function: a tale of two receptors
RL Carhart-Harris, DJ Nutt
Journal of Psychopharmacology (2017) Vol. 31, Iss. 9, pp. 1091-1120
Open Access | Times Cited: 597
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Robin Carhart‐Harris, Guy M. Goodwin
Neuropsychopharmacology (2017) Vol. 42, Iss. 11, pp. 2105-2113
Open Access | Times Cited: 503
Psychedelics and Psychedelic-Assisted Psychotherapy
Collin Reiff, Elon E. Richman, Charles B. Nemeroff, et al.
American Journal of Psychiatry (2020) Vol. 177, Iss. 5, pp. 391-410
Closed Access | Times Cited: 451
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider, Katrin H. Preller
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 611-624
Closed Access | Times Cited: 412
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
Rafael Faria Sanches, Flávia de Lima Osório, Rafael G. dos Santos, et al.
Journal of Clinical Psychopharmacology (2015) Vol. 36, Iss. 1, pp. 77-81
Open Access | Times Cited: 410
Crystal Structure of an LSD-Bound Human Serotonin Receptor
Daniel Wacker, Sheng Wang, John D. McCorvy, et al.
Cell (2017) Vol. 168, Iss. 3, pp. 377-389.e12
Open Access | Times Cited: 405
Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)
Matthew M. Nour, Lisa Evans, David Nutt, et al.
Frontiers in Human Neuroscience (2016) Vol. 10
Open Access | Times Cited: 377
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation
Katrin H. Preller, Marcus Herdener, Thomas Pokorny, et al.
Current Biology (2017) Vol. 27, Iss. 3, pp. 451-457
Open Access | Times Cited: 341
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
Katrin H. Preller, Joshua B. Burt, Jie Lisa Ji, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 336
Predicting Responses to Psychedelics: A Prospective Study
Eline Haijen, Mendel Kaelen, Leor Roseman, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 322
Psychedelics, Meditation, and Self-Consciousness
Raphaël Millière, Robin Carhart‐Harris, Leor Roseman, et al.
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 305
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Anna Rickli, Olivier D. Moning, Marius C. Hoener, et al.
European Neuropsychopharmacology (2016) Vol. 26, Iss. 8, pp. 1327-1337
Open Access | Times Cited: 298
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos, Flávia de Lima Osório, José Alexandre S. Crippa, et al.
Therapeutic Advances in Psychopharmacology (2016) Vol. 6, Iss. 3, pp. 193-213
Open Access | Times Cited: 274
The paradoxical psychological effects of lysergic acid diethylamide (LSD)
Robin Carhart‐Harris, Mendel Kaelen, Mark Bolstridge, et al.
Psychological Medicine (2016) Vol. 46, Iss. 7, pp. 1379-1390
Open Access | Times Cited: 267
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
Frederick S. Barrett, Matthew P. Bradstreet, Jeannie‐Marie Leoutsakos, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 12, pp. 1279-1295
Open Access | Times Cited: 264
Effective connectivity changes in LSD-induced altered states of consciousness in humans
Katrin H. Preller, Adeel Razi, Peter Zeidman, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 7, pp. 2743-2748
Open Access | Times Cited: 259
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies
Kristoffer A. A. Andersen, Robin Carhart‐Harris, David Nutt, et al.
Acta Psychiatrica Scandinavica (2020) Vol. 143, Iss. 2, pp. 101-118
Closed Access | Times Cited: 256
Neuromodulatory Correlates of Pupil Dilation
Rylan S. Larsen, Jack Waters
Frontiers in Neural Circuits (2018) Vol. 12
Open Access | Times Cited: 246
Phenomenology, Structure, and Dynamic of Psychedelic States
Katrin H. Preller, Franz X. Vollenweider
Current topics in behavioral neurosciences (2016), pp. 221-256
Closed Access | Times Cited: 225
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
Juan F. López‐Giménez, Javier González‐Maeso
Current topics in behavioral neurosciences (2017), pp. 45-73
Open Access | Times Cited: 225
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
Anne Katrin Schlag, Jacob S. Aday, Iram Salam, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 3, pp. 258-272
Open Access | Times Cited: 222
Classical psychedelics for the treatment of depression and anxiety: A systematic review
Silvia Muttoni, Maddalena Ardissino, Christopher John
Journal of Affective Disorders (2019) Vol. 258, pp. 11-24
Closed Access | Times Cited: 218
Page 1 - Next Page

Scroll to top